VOIS Vocal Implant System
Glottic Insufficiency
Key Facts
About APrevent Medical
APrevent Medical is a private, commercial-stage medical device company specializing in the respiratory and ENT space, with a core focus on treating glottic insufficiency and dysarthria. The company's flagship products are the VOIS Vocal Implant System, a CE-marked and TFDA-approved adjustable long-term implant, and AiSpeak, an intelligible speech conversion SaaS platform for dysarthria patients. Recent milestones include winning the 2024 MedTech Innovator Asia Pacific Grand Finals, securing a $6M Series D funding round led by Taiwania Capital, and receiving prestigious awards in Taiwan and Germany, indicating strong clinical and market validation. APrevent operates with a hybrid business model of medical device sales and software-as-a-service.
View full company profile